Side-by-side comparison of AI visibility scores, market position, and capabilities
Windsor UK global hotel company (LSE: IHG) at $4.92B 2024 revenue with 6,800+ hotels in 100+ countries; record 714-hotel pipeline 2024 and 145M One Rewards members competing with Marriott and Hilton for hotel franchise and loyalty.
IHG Hotels & Resorts (InterContinental Hotels Group) is a Windsor, Berkshire, England-headquartered global hotel company — listed on the London Stock Exchange (LSE: IHG) and traded as ADRs in the US — operating 6,800+ hotels with 825,000+ rooms across 19 brands (InterContinental, Kimpton, voco, Crowne Plaza, Holiday Inn, Holiday Inn Express, Staybridge Suites, Ruby Hotels, and others) spanning luxury, lifestyle, premium, essentials, and extended stay segments in 100+ countries. In 2024, IHG delivered $4.92 billion in revenue (6.47% year-over-year growth), signed a record 714 hotels into the development pipeline (34% increase year-over-year), opened 371 new properties, and returned $1 billion+ to shareholders. IHG One Rewards — the hospitality industry's first and longest-running loyalty program (launched 1983 as Priority Club Rewards) — has 145+ million members who book 60% of all IHG room nights. CEO Elie Maalouf leads the company since July 2023. IHG acquired Ruby Hotels (European lifestyle brand) in 2024, adding a growth urban lifestyle concept.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.